Pantoprazol Stada (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Stada, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adult patients. GNH USA supplies Pantoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor used to reduce gastric acid secretion in several acid‑related conditions.

Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. Erosive oesophagitis: heals mucosal damage and prevents recurrence. Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, usually transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Hypomagnesemia: low serum magnesium levels, potentially causing muscle cramps. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Acute pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, consider patient‑specific factors and monitor for potential complications.

Assess renal function: dose adjustment may be needed in severe impairment. Monitor magnesium levels: prolonged use can lead to hypomagnesemia. Evaluate liver disease: use with caution in moderate to severe hepatic impairment. Use caution in elderly patients: increased susceptibility to adverse effects. Review concomitant medications: potential for drug‑drug interactions. Store at room temperature: keep in the original container, protect from moisture and heat.

Pantoprazol Stada may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Atazanavir (HIV protease inhibitor): reduced absorption and efficacy. - Clarithromycin (macrolide antibiotic): increased pantoprazole plasma concentrations. - Methotrexate (high‑dose): heightened toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Diazepam: may raise serum levels, enhancing sedative effects. - Digoxin: potential increase in serum concentration, necessitating dose adjustment.